Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jimenez

Showing results (111-120 of 132) with videos related to

Pageof 14
Sort By:
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 18, 2004
A novel promoter polymorphism in the gene encoding complement component 5 receptor 1 on chromosome 19q13.3 is not associated with asthma and atopy in three independent populationsK C Barnes, L Caraballo, M Muñoz, et al.
Rheumatology International|September 10, 2015
MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patientsJ F Mendoza Rincón, A K Rodríguez Elias, J M Fragoso, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2017
Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNAL Martorell, E Luce, J L Vazquez, et al.
Transplantation Proceedings|September 10, 2003
Simultaneous liver-kidney transplant for combined renal and hepatic end-stage diseaseE Moreno-Gonzalez, J C Meneu-Diaz, García García, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2012
Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012S Jimenez-Jorge, S de Mateo, F Pozo, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 15, 2014
Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA studyS Jimenez-Jorge, F Pozo, S de Mateo, et al.
British Journal of Cancer|January 14, 2022
Cell-free DNA analysis in current cancer clinical trials: a reviewM Cisneros-Villanueva, L Hidalgo-Pérez, M Rios-Romero, et al.
Transplantation Proceedings|September 1, 2009
Disseminated nocardiosis: a rare infectious complication following non-heart-beating donor liver transplantationS Jimenez-Galanes Marchan, J C Meneu Díaz, O Caso Maestro, et al.
Annals of Internal Medicine|February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyF M Wigley, R A Wise, J R Seibold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)R Garcia-Sanz, A Sureda, F de la Cruz, et al.
Pageof 14

Showing results (111-120 of 132) with videos related to

Sort By:
Pageof 14
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|May 18, 2004
A novel promoter polymorphism in the gene encoding complement component 5 receptor 1 on chromosome 19q13.3 is not associated with asthma and atopy in three independent populationsK C Barnes, L Caraballo, M Muñoz, et al.
Rheumatology International|September 10, 2015
MHC2TA and FCRL3 genes are not associated with rheumatoid arthritis in Mexican patientsJ F Mendoza Rincón, A K Rodríguez Elias, J M Fragoso, et al.
Journal of Thrombosis and Haemostasis : JTH|August 24, 2017
Advanced cell-based modeling of the royal disease: characterization of the mutated F9 mRNAL Martorell, E Luce, J L Vazquez, et al.
Transplantation Proceedings|September 10, 2003
Simultaneous liver-kidney transplant for combined renal and hepatic end-stage diseaseE Moreno-Gonzalez, J C Meneu-Diaz, García García, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2012
Early estimates of the effectiveness of the 2011/12 influenza vaccine in the population targeted for vaccination in Spain, 25 December 2011 to 19 February 2012S Jimenez-Jorge, S de Mateo, F Pozo, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|March 15, 2014
Influenza vaccine effectiveness in Spain 2013/14: subtype-specific early estimates using the cycEVA studyS Jimenez-Jorge, F Pozo, S de Mateo, et al.
British Journal of Cancer|January 14, 2022
Cell-free DNA analysis in current cancer clinical trials: a reviewM Cisneros-Villanueva, L Hidalgo-Pérez, M Rios-Romero, et al.
Transplantation Proceedings|September 1, 2009
Disseminated nocardiosis: a rare infectious complication following non-heart-beating donor liver transplantationS Jimenez-Galanes Marchan, J C Meneu Díaz, O Caso Maestro, et al.
Annals of Internal Medicine|February 1, 1994
Intravenous iloprost infusion in patients with Raynaud phenomenon secondary to systemic sclerosis. A multicenter, placebo-controlled, double-blind studyF M Wigley, R A Wise, J R Seibold, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 19, 2019
Brentuximab vedotin and ESHAP is highly effective as second-line therapy for Hodgkin lymphoma patients (long-term results of a trial by the Spanish GELTAMO Group)R Garcia-Sanz, A Sureda, F de la Cruz, et al.
Pageof 14